Form 4: Intuitive Surgical EVP Exercises, Sells Stock

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, exercised stock options and sold shares, while also acquiring performance stock units.

Summary

• Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical Inc. (ISRG), reported transactions involving common stock and derivative securities.
• On January 29, 2026, Curet exercised 126 non-qualified stock options at a price of $208.9 per share.
• Concurrently, Curet sold 126 shares of common stock at a price of $520.02 per share.
• These transactions were conducted in accordance with a Rule 10b5-1 trading plan, which expires on July 29, 2026.
• Curet also acquired 5,585 Performance Stock Units (PSUs) on January 28, 2026, for which the performance criteria have been achieved.
• These PSUs, initially granted on February 28, 2023, are scheduled to vest on February 28, 2026, contingent on continuous service.
• Following these transactions, Curet beneficially owns 125 derivative securities (non-qualified stock options), 5,585 PSUs, and 353 shares of common stock indirectly through a trust.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive event. While the sale of shares by an insider could be seen as neutral, it was part of a pre-arranged 10b5-1 plan and offset by an option exercise. The achievement of performance criteria for a significant number of PSUs is a clear positive indicator of company performance and executive incentive alignment.

Positives

• The performance criteria for 5,585 Performance Stock Units (PSUs) granted to the EVP & Chief Medical Officer have been achieved, indicating successful attainment of company goals.
• The exercise of stock options at a lower price ($208.9) and subsequent sale at a higher price ($520.02) demonstrates a profitable transaction for the insider.

Negatives

• The sale of 126 shares of common stock by an executive, even under a pre-arranged plan, could be perceived as a slight negative by some investors, though it was offset by an option exercise.

Future Outlook

The acquired Performance Stock Units (PSUs) are scheduled to vest on February 28, 2026, subject to the reporting person's continuous service. The Rule 10b5-1 trading plan under which these transactions occurred will expire on July 29, 2026.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under pre-arranged Rule 10b5-1 plans, are a routine part of executive compensation and personal financial management. While they provide transparency into executive holdings, these specific transactions do not directly reflect broader industry trends or competitive dynamics within the medical device or robotic surgery sector.

Corporate Governance

Related Party Transactions

• Myriam Curet beneficially owns 353 shares of common stock indirectly through a trust.

Stakeholder Impact

• Shareholders gain transparency into executive stock ownership and trading activities, which can influence investor sentiment regarding management's confidence in the company.
• Employees, particularly those with similar equity compensation, may see the achievement of PSU performance criteria as a positive signal regarding company performance and potential for their own awards.

Next Steps

• Vesting of 5,585 Performance Stock Units (PSUs) on February 28, 2026, contingent on continuous service.
• Expiration of the Rule 10b5-1 trading plan on July 29, 2026.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions under a pre-arranged 10b5-1 plan, including an option exercise and corresponding share sale, alongside the achievement of performance stock units. While the PSU achievement is positive, the overall activity is standard for executive compensation and does not provide new material information to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as the filing does not present a compelling reason to buy or sell based solely on these transactions.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Trading, Stock Options, Performance Stock Units, Executive Compensation, Rule 10b5-1 Plan, Medical Devices, Robotic Surgery